Search research articles
Contact Us
Filters
Showing results (111-120 of 121) with videos related to
Page
of 13
Sort By:
Neuro-Oncology Advances
|
November 29, 2023
NRG/RTOG 0837: Randomized, phase II, double-blind, placebo-controlled trial of chemoradiation with or without cediranib in newly diagnosed glioblastoma
Tracy T Batchelor, Minhee Won, Arnab Chakravarti, et al.
Journal of Neuro-Oncology
|
March 7, 2013
The effect of tumor subtype on the time from primary diagnosis to development of brain metastases and survival in patients with breast cancer
Paul W Sperduto, Norbert Kased, David Roberge, et al.
International Journal of Radiation Oncology, Biology, Physics
|
April 19, 2011
Effect of tumor subtype on survival and the graded prognostic assessment for patients with breast cancer and brain metastases
Paul W Sperduto, Norbert Kased, David Roberge, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 29, 2011
Summary report on the graded prognostic assessment: an accurate and facile diagnosis-specific tool to estimate survival for patients with brain metastases
Paul W Sperduto, Norbert Kased, David Roberge, et al.
Neuro-Oncology
|
March 5, 2019
A multi-institutional analysis of presentation and outcomes for leptomeningeal disease recurrence after surgical resection and radiosurgery for brain metastases
Roshan S Prabhu, Brandon E Turner, Anthony L Asher, et al.
International Journal of Radiation Oncology, Biology, Physics
|
October 1, 2025
Tumor Treating Fields (TTFields) therapy after stereotactic radiosurgery for brain metastases from non-small cell lung cancer: final results of the phase 3 METIS study
Minesh P Mehta, Vinai Gondi, Manmeet Singh Ahluwalia, et al.
International Journal of Radiation Oncology, Biology, Physics
|
April 7, 2020
Phase 2 Study of a Temozolomide-Based Chemoradiation Therapy Regimen for High-Risk, Low-Grade Gliomas: Long-Term Results of Radiation Therapy Oncology Group 0424
Barbara J Fisher, Stephanie L Pugh, David R Macdonald, et al.
Advances in Radiation Oncology
|
March 18, 2021
Leptomeningeal disease and neurologic death after surgical resection and radiosurgery for brain metastases: A multi-institutional analysis
Roshan S Prabhu, Brandon E Turner, Anthony L Asher, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
September 19, 2019
Multi-institutional validation of brain metastasis velocity, a recently defined predictor of outcomes following stereotactic radiosurgery
Emory R McTyre, Michael H Soike, Michael Farris, et al.
The New England Journal of Medicine
|
April 10, 2021
Oncolytic HSV-1 G207 Immunovirotherapy for Pediatric High-Grade Gliomas
Gregory K Friedman, James M Johnston, Asim K Bag, et al.
Page
of 13
Search research articles
Search
Showing results (111-120 of 121) with videos related to
Sort By:
Page
of 13
Neuro-Oncology Advances
|
November 29, 2023
NRG/RTOG 0837: Randomized, phase II, double-blind, placebo-controlled trial of chemoradiation with or without cediranib in newly diagnosed glioblastoma
Tracy T Batchelor, Minhee Won, Arnab Chakravarti, et al.
Journal of Neuro-Oncology
|
March 7, 2013
The effect of tumor subtype on the time from primary diagnosis to development of brain metastases and survival in patients with breast cancer
Paul W Sperduto, Norbert Kased, David Roberge, et al.
International Journal of Radiation Oncology, Biology, Physics
|
April 19, 2011
Effect of tumor subtype on survival and the graded prognostic assessment for patients with breast cancer and brain metastases
Paul W Sperduto, Norbert Kased, David Roberge, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 29, 2011
Summary report on the graded prognostic assessment: an accurate and facile diagnosis-specific tool to estimate survival for patients with brain metastases
Paul W Sperduto, Norbert Kased, David Roberge, et al.
Neuro-Oncology
|
March 5, 2019
A multi-institutional analysis of presentation and outcomes for leptomeningeal disease recurrence after surgical resection and radiosurgery for brain metastases
Roshan S Prabhu, Brandon E Turner, Anthony L Asher, et al.
International Journal of Radiation Oncology, Biology, Physics
|
October 1, 2025
Tumor Treating Fields (TTFields) therapy after stereotactic radiosurgery for brain metastases from non-small cell lung cancer: final results of the phase 3 METIS study
Minesh P Mehta, Vinai Gondi, Manmeet Singh Ahluwalia, et al.
International Journal of Radiation Oncology, Biology, Physics
|
April 7, 2020
Phase 2 Study of a Temozolomide-Based Chemoradiation Therapy Regimen for High-Risk, Low-Grade Gliomas: Long-Term Results of Radiation Therapy Oncology Group 0424
Barbara J Fisher, Stephanie L Pugh, David R Macdonald, et al.
Advances in Radiation Oncology
|
March 18, 2021
Leptomeningeal disease and neurologic death after surgical resection and radiosurgery for brain metastases: A multi-institutional analysis
Roshan S Prabhu, Brandon E Turner, Anthony L Asher, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
September 19, 2019
Multi-institutional validation of brain metastasis velocity, a recently defined predictor of outcomes following stereotactic radiosurgery
Emory R McTyre, Michael H Soike, Michael Farris, et al.
The New England Journal of Medicine
|
April 10, 2021
Oncolytic HSV-1 G207 Immunovirotherapy for Pediatric High-Grade Gliomas
Gregory K Friedman, James M Johnston, Asim K Bag, et al.
Page
of 13